john a. jernigan, md, ms division of healthcare quality promotion
DESCRIPTION
Surprising Victories Against Old Foes: New Hope for Prevention and Control of Healthcare-Associated MRSA Infections. John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Atlanta, Georgia. - PowerPoint PPT PresentationTRANSCRIPT
Surprising Victories Against Old Foes: New Hope for
Prevention and Control of Healthcare-Associated MRSA
Infections
John A. Jernigan, MD, MSDivision of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Atlanta, Georgia
What is the Preventable Fraction of Healthcare Associated
Infections?
What is the Preventable Fraction of Healthcare Associated
Infections?
• SENIC study results
• others
What is the Preventable Fraction of Healthcare Associated
Infections?
• Some may have interpreted these data to mean that most healthcare associated infections are inevitable
• What impact has this had on the Psychology of prevention?
• How has this impacted how infection control programs operate?
Eliminating catheter-related bloodstream infections
in the intensive care unit
Berenholtz, S et al. Critical Care Medicine. 32(10):2014-2020, October 2004.
Maybe the Preventable Fraction is Much Larger than we Thought?
• Healthcare Epidemiologists have been afraid of using the “E” word (elimination) with regard to healthcare-associated infections, but recent successes suggest that perhaps we should have been using it more.
Are such goals appropriate for the problem of antimicrobial resistance,
with MRSA as a starting point?
0
10
20
30
40
50
60
70
1975 1979 1983 1987 1991 1995 1999
% R
esis
tant
National Nosocomial Infections Surveillance (NNIS) System
Emerging Prevalence of Methicillin-Resistance Among S. aureus in
U.S. Intensive Care Units
Rationale for Efforts to Prevent and Control Resistant Gram-positive Bacteria
• Emerging as dominant pathogens in healthcare-associated infections– for example:
• Between 1992-2002, among infections following CABG, cholecystectomy, colectomy, and total hip replacement, % S. aureus 16.6% -30.9%
• % S. aureus infections attributable to MRSA increased from 9.2% to 49.3%
• Treatment options are limited and less effective, may result in higher morbidity and mortality– Gonzalez Clin Infect Dis 1999;29:1171– Lucas Clin Infect Dis 1998;26:1127– Abramson ICHE 1999; 20:408-411 – Cheng et al J Hospital Infect 1988;12:91-101– Stosor et al. Arch Intern Med 1998; 158:522-527
Summary of Unadjusted Results of Studies Comparing Mortality of
MRSA and MSSA Bacteremia
Cosgrove et al. Clinical Infectious Diseases 2003:36;53-59
Rationale for Efforts to Prevent and Control Resistant Gram-positive Bacteria
• Prevalence of resistance leads to unfavorable antibiotic prescribing, and leads to more resistance– prevalent MRSA more glycopeptide
use more glycopeptide resistance
MRSA infections add to the total S. aureus infection rate
– Stamm Am J Infect Control 1993;21:70– Boyce J Infect Dis 1993;148:763– Chaix JAMA 1999; 282:1745-1751 – Jernigan ICHE 1995;16:686– Harbarth J Hosp Infect 2000:46;43
Therefore, preventing MRSA infections should result in decreased S. aureus infection rates
“Okay, so MRSA and antimicrobial resistance in general are important
problems, but they are different from bloodstream infections. It’s okay to
set bold goals for preventing bloodstream infections, but we could
never hope to be so successful against MRSA infection! Could we?”
0
10
20
30
40
50
60
70
1960 1967 1974 1981 1988 1995 2002
% R
esis
tant
USA
Emerging Prevalence of Methicillin-Resistance Among S. aureus in
U.S. Intensive Care Units
0
10
20
30
40
50
60
70
1960 1967 1974 1981 1988 1995 2002
% R
esis
tant
USA
Denmark
Emerging Prevalence of Methicillin-Resistance Among S. aureus in
U.S. Intensive Care Units
Methicillin-resistant Staphylococcus aureus in
Europe, 1999–2002Tiemersma et. al. Emerg Infect Dis
2004;10:1627-34
Methicillin-resistant Staphylococcus aureus in
Europe, 1999–2002Tiemersma et. al. Emerg Infect Dis
2004;10:1627-34
Can the experience in other countries be reproduced here?
0
0.5
1
1.5
2
Infe
ctio
ns
per
100
0 pt
day
s
2000 2001 2002 2003 2004
MRSA Infection Incidence by Fiscal Year,4W Unit, Pittsburgh VA, Oct 1999-Present
Overall RatesPre-intervention = 1.48 infections/1,000 pt daysPost-intervention = 0.68 infections/1,000 pt days
54% reduction, p=.04
Intervention
0
1
2
3
4
Infe
ctio
ns
per
100
0 pt
day
s
2001 2002 2003
MRSA Infection Incidence by Year,Medical ICU Hospital B, 2001-Present
Overall RatesPre-intervention = 3.82 infections/1,000 pt daysPost-intervention = 1.62 infections/1,000 pt days
58% reduction, p<.01
Intervention
Huang, S. IDSA 2005
There are a growing number of studies suggesting that US
healthcare facilities can successfully prevent MRSA infections
• A regional collaborative approach may be a good way to approach the MRSA problem:– Sharing of MRSA-carriers between facilities– Success at the community level may be more
readily accepted as generalizable– Need to agree on common system for measuring
outcome, but there is room for alternative approaches to prevention. One size may not fit all.
– Successes can be shared and spread across the community
Summary
• We (healthcare epidemiologists) may have badly underestimated the preventable fraction of healthcare-associated infections
• Regional/community collaboratives have been effective in achieving major reductions in healthcare-associated infections
• MRSA is an important patient safety issue that needs addressing.
Summary (continued)
• MRSA infections can be prevented, even in endemic settings
• Regional collaboration on MRSA prevention may have particular advantages.
• Successful MRSA prevention across a region would represent a major advance for infection control, and would have implications for control of other antimicrobial resistant infections